Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM184A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | ARRDC2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ARSE | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | HSPA14 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | SWAP70 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | MAPKAPK2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | SEC16B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | DCAF8L2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | STAP1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | NTF3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |